American pharmaceutical giant says the federal government has benchmarked the value of the diabetes drug against a 20-year-old medicine no longer sold in Australia.
Drug company Lilly refuses to list Mounjaro on PBS, says price too low
Sam Irvine·AFR··1 min read
A
Continue reading on AFR
This article was sourced from AFR's RSS feed. Visit the original for the complete story.